Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000454
Filing Date
2025-03-26
Accepted
2025-03-26 07:15:24
Documents
80
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lptx-20241231x10k.htm   iXBRL 10-K 1959853
2 EX-19.1 lptx-20241231xex19d1.htm EX-19.1 63728
3 EX-21.1 lptx-20241231xex21d1.htm EX-21.1 7618
4 EX-23.1 lptx-20241231xex23d1.htm EX-23.1 2479
5 EX-31.1 lptx-20241231xex31d1.htm EX-31.1 14177
6 EX-32.1 lptx-20241231xex32d1.htm EX-32.1 8023
  Complete submission text file 0001410578-25-000454.txt   8040460

Data Files

Seq Description Document Type Size
7 EX-101.SCH lptx-20241231.xsd EX-101.SCH 57126
8 EX-101.CAL lptx-20241231_cal.xml EX-101.CAL 53818
9 EX-101.DEF lptx-20241231_def.xml EX-101.DEF 195375
10 EX-101.LAB lptx-20241231_lab.xml EX-101.LAB 543706
11 EX-101.PRE lptx-20241231_pre.xml EX-101.PRE 371697
83 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20241231x10k_htm.xml XML 1191939
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37990 | Film No.: 25770121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)